Glaukos
GKOS
159 hedge funds and large institutions have $2.41B invested in Glaukos in 2019 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 69 increasing their positions, 33 reducing their positions, and 20 closing their positions.
109% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 33
75% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 20
9% more funds holding
Funds holding: 146 → 159 (+13)
3% less capital invested
Capital invested by funds: $2.49B → $2.41B (-$79.1M)
5.98% less ownership
Funds ownership: 107.94% → 101.96% (-6%)
47% less call options, than puts
Call options by funds: $5.54M | Put options by funds: $10.5M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$94.2M |
| 2 |
IVM
InterWest Venture Management
San Francisco,
California
|
+$61M |
| 3 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$45.7M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$32.3M |
| 5 |
Morgan Stanley
New York
|
+$30.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$35M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$26.3M |
| 3 |
William Blair Investment Management
Chicago,
Illinois
|
-$25.3M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$19.7M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$15.6M |
GKOS Hedge Fund Activity: Q4 2019 in Review
159 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Glaukos (GKOS) for Q4 2019, worth a combined $2.41B — down 3.2% from $2.49B a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new GKOS positions and 20 closed out — a net gain of 15 holders — while 69 added to existing stakes and 33 trimmed.
The largest buyer was OrbiMed, opening a new position worth an estimated $94.2M. The largest seller was Lord, Abbett & Co, cutting an estimated $35M.
- 159 institutional investors held Glaukos (GKOS) as of Q4 2019, up from 146 in Q3 2019.
- Funds reported $2.41B of Glaukos stock for Q4 2019, down 3.2% quarter-over-quarter.
- 35 funds opened new Glaukos positions in Q4 2019 and 20 closed out, a net change of +15 holders.
- The largest Glaukos buyer in Q4 2019 was OrbiMed, an estimated $94.2M added.
- The largest Glaukos seller in Q4 2019 was Lord, Abbett & Co, an estimated $35M sold.
Based on aggregated 13F filings for Q4 2019.